Access to Essential Medicines for Noncommunicable Diseases during the COVID-19 Pandemic
Other Language Versions
Abstract
Appropriate and adequate management of people with noncommunicable diseases (NCDs) includes access to essential NCD medicines. Disrupted access to chronic medication for hypertension, diabetes, heart disease, mental health disorders, cancer, and asthma could result in severe disease exacerbation and potentially death.
Subject
Collections
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO
Related items
Showing items related by title, author, creator and subject.
-
Preventive chemotherapy for neglected infectious diseases: Manual for the design and use of record sheets
(Washington, D.C., PAHO, 2017-12)[Introduction]. Neglected infectious diseases (NIDs) affect populations living in less developed socioeconomic conditions, with geographical and cultural barriers that hinder their access to health services. Due to their ... -
A four-step process for building sustainable access to diagnosis and treatment of Chagas disease
(2019-09)[ABSTRACT]. The vast majority of people with Chagas disease (CD) are undiagnosed and untreated. Improving access to diagnosis and treatment for CD involves confronting a wide range of barriers. This report discusses a ... -
Profile of capacity and response to noncommunicable diseases and their risk factors in the Region of the Americas. Country capacity survey results, 2015
(Washington, D.C, PAHO, 2017-06)[Preface]. The rise in noncommunicable diseases (NCDs) is increasingly undermining sustainable development, especially in low- and middle-income countries which suffer the highest burden of disease. Over the past several ...
